This week, University of Oxford researchers published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics \u2013 as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
Results of MOSAIC, a European observational study led by researchers at PSI and ISARIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.
A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
A brand-new season of The Oxford Colloquy \u2013 a podcast series of conversations with leading experts in science and healthcare \u2013 is launched this week by Oxford Vaccine Group.
Launch of UK trial is major milestone in developing a vaccine against Marburg virus \u2013 a highly virulent disease that is fatal in up to 88% of cases.
PSI scientists are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
The exhibition, which features stories and items from University of Oxford researchers, explores the worldwide effort to develop vaccines against COVID-19 and shares the inspiring stories of scientists collaborating around the globe to save lives. Closing on 12 May, the exhibition has welcomed millions of visitors in London, India and China.
A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
The University of Oxford this week welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
A partnership between CEPI, Barinthus Biotherapeutics and the University of Oxford aims to fast-track the development of a potential vaccine for the prevention of Middle East Respiratory Syndrome (MERS).
Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford\u2019s vaccine laboratories as part of a two-day meeting of the global coalition.
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Jun\u00edn virus, with a new project led by Professor Teresa Lambe.
![\"\"](\"https://www.psi.ox.ac.uk/news-and-opinion/new-paper-outlines-ethical-issues-in-clinical-metagenomics/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n